Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Slater

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
ESC Heart Failure|June 7, 2024
Predicting cardiovascular events with fluoropyrimidine chemotherapy using a standard cardiovascular risk calculatorAderonke Abiodun, Marianne Shawe-Taylor, Sara Tyebally, et al.
Breast Cancer Research and Treatment|April 14, 2022
Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancerTemidayo A Fadelu, Parsa Erfani, Joarly Lormil, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesotheliomaJustin Stebbing, Thomas Powles, Kirsty McPherson, et al.
Advances in Therapy|June 7, 2015
Effect of Food on the Pharmacokinetics of Olaparib after Oral Dosing of the Capsule Formulation in Patients with Advanced Solid TumorsChristian Rolfo, Helen Swaisland, Karin Leunen, et al.
British Journal of Cancer|April 18, 2026
PD-L1 CPS in gastroesophageal cancer: differences in routine care versus Checkmate 649 and implications for biopsy-site choice and assay standardisationLucy Flanders, Thomas Savy, Miriam Ficial, et al.
Current Treatment Options in Oncology|August 10, 2019
Advanced Imaging Modalities to Monitor for CardiotoxicityAndreas Seraphim, Mark Westwood, Anish N Bhuva, et al.
BMC Cancer|March 24, 2021
PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinomaDavid J Pinato, Alessio Cortellini, Ajithkumar Sukumaran, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2013
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)Gary Middleton, Sarah Brown, Catherine Lowe, et al.
BMJ Oncology|January 31, 2025
Association of pre-existing cardiovascular disease with administration of fluoropyrimidine chemotherapy in patients with gastrointestinal malignanciesAderonke Temilade Abiodun, Chengsheng Ju, Catherine A Welch, et al.
JACC. Cardiooncology|April 9, 2025
Fluoropyrimidine Chemotherapy and the Risk of Death and Cardiovascular Events in Patients With Gastrointestinal CancerAderonke T Abiodun, Chengsheng Ju, Catherine A Welch, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
ESC Heart Failure|June 7, 2024
Predicting cardiovascular events with fluoropyrimidine chemotherapy using a standard cardiovascular risk calculatorAderonke Abiodun, Marianne Shawe-Taylor, Sara Tyebally, et al.
Breast Cancer Research and Treatment|April 14, 2022
Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancerTemidayo A Fadelu, Parsa Erfani, Joarly Lormil, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesotheliomaJustin Stebbing, Thomas Powles, Kirsty McPherson, et al.
Advances in Therapy|June 7, 2015
Effect of Food on the Pharmacokinetics of Olaparib after Oral Dosing of the Capsule Formulation in Patients with Advanced Solid TumorsChristian Rolfo, Helen Swaisland, Karin Leunen, et al.
British Journal of Cancer|April 18, 2026
PD-L1 CPS in gastroesophageal cancer: differences in routine care versus Checkmate 649 and implications for biopsy-site choice and assay standardisationLucy Flanders, Thomas Savy, Miriam Ficial, et al.
Current Treatment Options in Oncology|August 10, 2019
Advanced Imaging Modalities to Monitor for CardiotoxicityAndreas Seraphim, Mark Westwood, Anish N Bhuva, et al.
BMC Cancer|March 24, 2021
PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinomaDavid J Pinato, Alessio Cortellini, Ajithkumar Sukumaran, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2013
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)Gary Middleton, Sarah Brown, Catherine Lowe, et al.
BMJ Oncology|January 31, 2025
Association of pre-existing cardiovascular disease with administration of fluoropyrimidine chemotherapy in patients with gastrointestinal malignanciesAderonke Temilade Abiodun, Chengsheng Ju, Catherine A Welch, et al.
JACC. Cardiooncology|April 9, 2025
Fluoropyrimidine Chemotherapy and the Risk of Death and Cardiovascular Events in Patients With Gastrointestinal CancerAderonke T Abiodun, Chengsheng Ju, Catherine A Welch, et al.
Pageof 3